Most drug development organizations have two basic needs.  The first need is to standardize the reporting and second, to streamline the reporting process. SAS-generated reports are a
key component of most clinical study reports that are included in a regulatory submission.  The reporting of most clinical data is similar from study to study and therefore can be standardized.  This standardization creates an opportunity for SAS macro-driven reporting.  

READ MORE

 

Latest News & Articles

12
Mar2020

Harmonious approach of regulatory data migration

A holistic solution platform that can manage the complexities of regulatory operations ......

31
Dec2019

Encouraging patient-centric innovation in pharma

Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions...